ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

CDC Awaits Results Of Viral Cultures Of Bahama’s Serum For AIDs Contamination Before Taking Action

July 19, 1985

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006

UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.

February 25, 2000

Moratorium Asked On New Bladder Cancer Screening

January 27, 1978

P01 Reviewers Asked To Look Closely At Number Of Projects

October 2, 1992

In Brief: INTRA-NCI Scramble For Funds involves “Tricks, Machinations, Day To Day Battle”

July 16, 1976